Ibezapolstat is a First-in-class and Orally Active DNA polymerase IIIC Inhibitor
The Gram-positive obligate anaerobic spore-forming bacterium Clostridioides difficile is a nosocomial pathogen. The severity and prevalence of C. difficile infection (CDI) have caused the CDC to identify C. difficile as an 'urgent threat' and thus…